Julien Giron-Michel

5PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer cell biologyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma.

|Jan 18, 2025
State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Julien Giron-Michel, Maël Padelli, Estelle Oberlin

|Nov 13, 2021
IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?

Aurore Devocelle, Lola Lecru, Sophie Ferlicot

|Jun 02, 2021
BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.

Yuan Zhang, Aurore Devocelle, Christophe Desterke

|Jul 31, 2019
Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis.

Aurore Devocelle, Lola Lecru, Hélène François

Pageof 1

Frequent Collaborators

2 joint publications

Maël Padelli

1 joint publications

Bruno Azzarone

1 joint publications

Adlen Foudi

1 joint publications

Yunhua Chang